Abstract
The WHO has estimated that one-fourth of the world’s population harbor a latent infection by MTB, and around 100-200 million individuals eventually develop an active TB. To make matters worse, drug-resistant MTB as well as the co-infection between MTB and HIV has further aggravated the mortality and spread of this disease. The quinolones have contributed an increasingly important chapter to the evolution of antimicrobials, and some of them were recommended as the second-line agents for the treatment of TB by WHO. Numerous 2-quinolone-based derivatives have been synthesized for searching new anti-TB agents, and some of them showed promising potency. This review aims to outline the recent advances made towards the discovery of 2-quinolone-based derivatives as potential anti-TB agents, and their structure-activity relationships are also discussed.
Keywords: Quinolone, hybrids, anti-mycobacterial, anti-tubercular, structure-activity relationship, co-infection.
Graphical Abstract
Anti-Infective Agents
Title:Recent Advances of 2-Quinolone-Based Derivatives as Anti-Tubercular Agents
Volume: 16 Issue: 1
Author(s): Xiaocheng Liu, Jialun Deng, Zhi Xu*Zao-Sheng Lv
Affiliation:
- Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials, Wuhan University of Science and Technology, Hubei,China
Keywords: Quinolone, hybrids, anti-mycobacterial, anti-tubercular, structure-activity relationship, co-infection.
Abstract: The WHO has estimated that one-fourth of the world’s population harbor a latent infection by MTB, and around 100-200 million individuals eventually develop an active TB. To make matters worse, drug-resistant MTB as well as the co-infection between MTB and HIV has further aggravated the mortality and spread of this disease. The quinolones have contributed an increasingly important chapter to the evolution of antimicrobials, and some of them were recommended as the second-line agents for the treatment of TB by WHO. Numerous 2-quinolone-based derivatives have been synthesized for searching new anti-TB agents, and some of them showed promising potency. This review aims to outline the recent advances made towards the discovery of 2-quinolone-based derivatives as potential anti-TB agents, and their structure-activity relationships are also discussed.
Export Options
About this article
Cite this article as:
Liu Xiaocheng , Deng Jialun , Xu Zhi *, Lv Zao-Sheng, Recent Advances of 2-Quinolone-Based Derivatives as Anti-Tubercular Agents, Anti-Infective Agents 2018; 16 (1) . https://dx.doi.org/10.2174/2211352516666180215151216
DOI https://dx.doi.org/10.2174/2211352516666180215151216 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials
Infectious Disorders - Drug Targets Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews The Diagnosis of Drug-Induced Liver Disease
Current Clinical Pharmacology Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability
Current Neuropharmacology Anti-VEGF Therapy for Retinal Vein Occlusions
Current Drug Targets Green Synthesis of N-doped Graphene Nanosheets by Cow Urine
Current Graphene Science (Discontinued) 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities
Mini-Reviews in Medicinal Chemistry Structure-Activity Design, Synthesis and Biological Activity of Newer Imidazole- Triazine Clubbed Derivatives as Antimicrobial and Antitubercular Agents
Letters in Organic Chemistry Recent Advances in New Structural Classes of Anti-Tuberculosis Agents
Current Medicinal Chemistry Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment
Current Cancer Drug Targets Structure and Function of L,D- and D,D-Transpeptidase Family Enzymes from Mycobacterium tuberculosis
Current Medicinal Chemistry Anti-Infective Peptides to Enhance the Host Innate Response: Design, Development and Delivery
Protein & Peptide Letters Therapy of XDR TB with Thioridazine a Drug Beyond Patent Protection but Eligible for Patent “As New Use”
Recent Patents on Anti-Infective Drug Discovery Glycosyltransferases, Important Tools for Drug Design
Current Topics in Medicinal Chemistry Immunization with Peptide-Protein Conjugates: Impact on Benchmarking B-Cell Epitope Prediction for Vaccine Design
Protein & Peptide Letters Sleep in Pediatric Pulmonary Diseases
Current Respiratory Medicine Reviews From Protein-Protein Interactions to Rational Drug Design: Are Computational Methods Up to the Challenge?
Current Topics in Medicinal Chemistry Gene Therapy by Liver Transplantation and Single Stranded Oligonucleotides (SSOs) in Familial Amyloidotic Polyneuropathy (FAP)
Current Pharmacogenomics ITK Inhibitors in Inflammation and Immune-Mediated Disorders
Current Topics in Medicinal Chemistry Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds
Anti-Cancer Agents in Medicinal Chemistry